Table 5 Distribution of Clinicopathological parameters in each molecular subtypes of breast cancer among the study participants
Clinico-pathological Parameters | Luminal A | Luminal B | HER2-enriched | Triple Negative | Total | p-value |
|---|---|---|---|---|---|---|
Median age at diagnosis(min-max) | 47(22–75) | 35(22–53) | 41(27–65) | 46(29–60) |  | 0.009 |
Tumor grade, n (%) | ||||||
 I | 5(18) | 0(0) | 1(13) | 1(6) | 7(9) |  |
 II | 11(39) | 8(36) | 5(63) | 7(39) | 31(41) | 0.243 |
 III | 12(43) | 14(64) | 2(25) | 10(55) | 38(50) |  |
Stage, n (%) | ||||||
 I | 9(24) | 5(19) | 1(11) | 4(18) | 19(20) |  |
 II | 13(35) | 13(48) | 1(11) | 9(41) | 36(38) | 0.632 |
 III | 14(38) | 8(30) | 6(67) | 8(36) | 36(38) |  |
 IV | 1(3) | 1(4) | 1(11) | 1(5) | 4(4) |  |
Histological type, n (%) | ||||||
 Ductal | 29(70) | 15(60) | 7(80) | 17(80) | 66(69) | 0.708 |
 Lobular | 2(10) | 4(10) | 0(0) | 0(0) | 6(6) | |
 Others/Unknown | 9(20) | 8(30) | 2(20) | 5(20) | 24(25) | |